Brevan Howard Capital Management’s Bath & Body Works BBWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$416K Buy
+22,293
New +$482K ﹤0.01% 1414
2025
Q4
Sell
-50,799
Closed -$1.31M 1804
2025
Q3
$1.31M Sell
50,799
-17,858
-26% -$529K 0.01% 776
2025
Q2
$2.06M Sell
68,657
-22,894
-25% -$670K 0.01% 722
2025
Q1
$2.78M Buy
+91,551
New +$3.24M 0.03% 236
2024
Q4
Sell
-36,815
Closed -$1.18M 1049
2024
Q3
$1.18M Buy
+36,815
New +$1.22M 0.01% 404
2024
Q1
Sell
-8,906
Closed -$384K 1017
2023
Q4
$384K Buy
8,906
+2,165
+32% +$73.1K ﹤0.01% 607
2023
Q3
$228K Sell
6,741
-7,466
-53% -$271K ﹤0.01% 299
2023
Q2
$533K Buy
+14,207
New +$519K 0.01% 128

Other funds holding BBWI

Brevan Howard Capital Management's BBWI Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Bath & Body Works (BBWI) in Q1 2026: 22,293 shares worth $416K. The stake represents ﹤0.01% of the portfolio and ranks #1414 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in BBWI as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in BBWI in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.78M in Q1 2025. 466 funds tracked by Wall St. Rank hold BBWI as of Q1 2026.

  • Brevan Howard Capital Management held 22,293 shares of Bath & Body Works worth $416K as of Q1 2026.
  • Bath & Body Works was a new Brevan Howard Capital Management position in Q1 2026.
  • Bath & Body Works made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1414 holding.
  • Brevan Howard Capital Management first reported a position in Bath & Body Works in Q2 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Bath & Body Works position peaked at $2.78M in Q1 2025.
  • 466 funds tracked by Wall St. Rank held Bath & Body Works as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.